Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Adcortyl Intra-articular / Intradermal 50mg/5ml suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) |
| BNF code | 1001022U0BBABAC |
| Virtual Medicinal Product | Triamcinolone acetonide 50mg/5ml suspension for injection vials |
| Name | Adcortyl Intra-articular / Intradermal 50mg/5ml suspension for injection vials |
| Abbreviated name | Adcortyl Intra-articular / Intradermal 50mg/5ml inj vials |
| Date of name applicability | 15 Jun 2004 |
| Previous name | Adcortyl Intra-articular / Intradermal 10mg/ml injection 5ml vials |
| Supplier | Bristol-Myers Squibb Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intradermal |
| Licensed Route | |
| Licenced route | Intraarticular |
| Actual Medicinal Product Packs | |
| Adcortyl Intra-articular / Intradermal 50mg/5ml suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.